A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Clinical trial NCT00000713 · COMPLETED
Trial details
- NCT number
- NCT00000713
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.